Gold Pressed Latinum (CURRENCY:GPL) traded 2.2% lower against the dollar during the 1 day period ending at 17:00 PM E.T. on May 13th. In the last seven days, Gold Pressed Latinum has traded down 13.3% against the dollar. Gold Pressed Latinum has a total market cap of $67,024.00 and approximately
Listed on the Thai Stock Exchange and also traded over the US OTC markets via ADRs (OTCPK:BLJZY), Berli Jucker (BJC) is a leading integrated Thai retailer with operating presence across various countries in Southeast Asia.
SiteOne Landscape Supply (NYSE:SITE) had its target price hoisted by Deutsche Bank from $78.00 to $81.00 in a report released on Friday morning. The firm currently has a buy rating on the industrial products company’s stock.
SITE has been the topic of a number of other research reports. Barclays set a $65.00 target price on SiteOne Landscape Supply and gave the company a hold rating....More>>>
A review of inflation, interest rates, capacity utilization, and inventory point more towards the middle stage of an expansion.
Basic Materials companies like chemical producers typical do well mid-cycle. Huntsman International has a solid balance sheet, lots of dry powder for strategic opportunities, strong margins, and industry-leading efficiency returns.
The stock looks relatively....More>>>
More often than not, dividend stocks are the “X-Factor” that propels the average investment portfolio to greatness over the long run. That’s because dividend stocks offer three key advantages that cause investors to seek them out.
The promises and perils of dividend investing
To begin with, dividend stocks are usually beacons of profitability. A company’s....More>>>
Nonprofit organization Oxfam presented a state of the world’s wealth analysis before Davos, a gathering of the world’s richest and most powerful people. Among the conclusions of the study is that the world adds a new billionaire every other day.
Another major conclusion of the study is that 1% of the world’s population controls 82% of the world’s wealth:
We are adding AstraZeneca ADR (NYSE:AZN) to our model portfolio as the next investment with the first price target = $39. The dividend yield is also attractive while we wait for the stock price appreciation. Several data readouts in 2017 could act as a catalyst for the stock price.
As one of the world's largest drugmakers, AbbVie Inc.(NYSE:ABBV)is made of many moving pieces. The big one at the top, Humira, can't keep growing forever. In fact, its main U.S. patent has already expired.
Luckily, a key component of the company's Humira replacement strategyis firing on al
Dividend aristocrats have a cult-like following among income investors, and for good reason. To be a dividend aristocrat, a company must be a member of the S&P 500 Index and have paid higher dividends for 25 consecutive years.
Businesses that have rewarded shareholders with rising divi
Marco Investment Management LLC cut its position in AbbVie Inc. (NYSE:ABBV) by 34.0% in the 1st quarter, HoldingsChannel.com reports. The firm owned 84,264 shares of the company’s stock after selling 43,388 shares during the quarter. AbbVie comprises 1.2% of Marco Investment Management LL
Stephens Inc. AR lowered its position in shares of AbbVie Inc. (NYSE:ABBV) by 29.1% in the first quarter, HoldingsChannel reports. The institutional investor owned 183,559 shares of the company’s stock after selling 75,317 shares during the period. Stephens Inc. AR’s holdings in Abb